Your Health, We Care
The targeted drug Sotorasib is a pioneering KRASG12C inhibitor, with the active ingredient Sotorasib and development code AMG510. It was previously accelerated for approval in the United States.
At present, the drug has been approved in 35 countries worldwide through the KRASG12C clinical development program.
Scan code
Whatsapp
Sotorasib, a small molecule inhibitor targeting the KRAS G12C gene mutation in non-small cell lung cancer (NSCLC), has garnered significant attention since its debut. Its distincti···【more】
Article source：Lucius LaosRelease date：2024-07-09Recommended：163
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
